HUTCHMED (China) Limited American Depositary Shares
HCM
HCM: HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
moreShow HCM Financials
Recent trades of HCM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HCM's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on HCM's company Twitter account
Number of mentions of HCM in WallStreetBets Daily Discussion
Recent insights relating to HCM
Recent picks made for HCM stock on CNBC
ETFs with the largest estimated holdings in HCM
Flights by private jets registered to HCM